These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7764416)

  • 21. Plant-based production of biopharmaceuticals.
    Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
    Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylotrophic yeast hansenula polymorpha as production organism for recombinant pharmaceuticals.
    Gellissen G; Melber K
    Arzneimittelforschung; 1996 Sep; 46(9):943-8. PubMed ID: 8876947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial systems for production of heterologous proteins.
    Zerbs S; Frank AM; Collart FR
    Methods Enzymol; 2009; 463():149-68. PubMed ID: 19892172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A probabilistic model for analyzing viral risks of plasma-derived medicinal products.
    Janssen MP; Over J; van der Poel CL; Cuijpers HT; van Hout BA
    Transfusion; 2008 Jan; 48(1):153-62. PubMed ID: 17894786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent advances in the production of heterologous proteins in filamentous fungi].
    Zhong Y; Wang X; Wang T
    Sheng Wu Gong Cheng Xue Bao; 2008 Apr; 24(4):531-40. PubMed ID: 18616158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion.
    Morello E; Bermúdez-Humarán LG; Llull D; Solé V; Miraglio N; Langella P; Poquet I
    J Mol Microbiol Biotechnol; 2008; 14(1-3):48-58. PubMed ID: 17957110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioreactor systems for the production of biopharmaceuticals from animal cells.
    Warnock JN; Al-Rubeai M
    Biotechnol Appl Biochem; 2006 Jul; 45(Pt 1):1-12. PubMed ID: 16764553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The past, present and future of transgenic bioreactors.
    Drohan WN
    Thromb Haemost; 1997 Jul; 78(1):543-7. PubMed ID: 9198212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Process technology for production and recovery of heterologous proteins with Pichia pastoris.
    Jahic M; Veide A; Charoenrat T; Teeri T; Enfors SO
    Biotechnol Prog; 2006; 22(6):1465-73. PubMed ID: 17137292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GMP issues for recombinant plant-derived pharmaceutical proteins.
    Fischer R; Schillberg S; Hellwig S; Twyman RM; Drossard J
    Biotechnol Adv; 2012; 30(2):434-9. PubMed ID: 21856403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manufacturing recombinant proteins in kg-ton quantities using animal cells in bioreactors.
    De Jesus M; Wurm FM
    Eur J Pharm Biopharm; 2011 Jun; 78(2):184-8. PubMed ID: 21256214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Finding one of a kind: advances in single-protein production.
    Falzon L; Suzuki M; Inouye M
    Curr Opin Biotechnol; 2006 Aug; 17(4):347-52. PubMed ID: 16828276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plant-derived vaccines and other therapeutics produced in contained systems.
    Franconi R; Demurtas OC; Massa S
    Expert Rev Vaccines; 2010 Aug; 9(8):877-92. PubMed ID: 20673011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in plant molecular farming.
    Obembe OO; Popoola JO; Leelavathi S; Reddy SV
    Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yeasts as a tool for heterologous gene expression.
    Mokdad-Gargouri R; Abdelmoula-Soussi S; Hadiji-Abbès N; Amor IY; Borchani-Chabchoub I; Gargouri A
    Methods Mol Biol; 2012; 824():359-70. PubMed ID: 22160908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous cell substrate considerations.
    Lubiniecki AS
    Bioprocess Technol; 1990; 10():495-513. PubMed ID: 1370028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant protein production in a variety of Nicotiana hosts: a comparative analysis.
    Conley AJ; Zhu H; Le LC; Jevnikar AM; Lee BH; Brandle JE; Menassa R
    Plant Biotechnol J; 2011 May; 9(4):434-44. PubMed ID: 21040385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals.
    Farshid M; Taffs RE; Scott D; Asher DM; Brorson K
    Curr Opin Biotechnol; 2005 Oct; 16(5):561-7. PubMed ID: 16095899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of protein supply on hepatic synthesis of plasma and constitutive proteins in lactating dairy cows.
    Raggio G; Lobley GE; Berthiaume R; Pellerin D; Allard G; Dubreuil P; Lapierre H
    J Dairy Sci; 2007 Jan; 90(1):352-9. PubMed ID: 17183103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progresses in recombinant human serum albumin].
    Manchu R; Zhang Y; Zhang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Aug; 26(4):900-3. PubMed ID: 19813636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.